Is pricing and reimbursement of medicines in urgent need of EU-level coordination?
The new trio of EU Council presidencies began this month, with the Dutch government overseeing the first six months of 2016. Slovakia and Malta follow.
All three are working together on shared priorities, but the Dutch are the first to take responsibility for the Council’s agenda. They are expected to seek Council Conclusions on a new approach to pharmaceuticals, focusing on access and costs.
What is the state of access to medicines in the EU?
Burson-Marsteller Brussels’ Healthcare and Food Practice has put together its view, assessing the value and feasibility of a new approach to medicines pricing, and the obstacles that stand in the way.
Download our briefing (PDF)
Words Claudia Louati and Sam Kynman
Photo (c) European Union 2016